Displaying results 1 - 3 of 3
Clear search
Nuclera Joins Tech Nation’s Future Fifty Program
Nuclera recognized as one of UK’s most exciting growth stage companies OfficialNuclera appoints Joseph Bertelsen as Chief Commercial Officer
Key appointment to lead global commercial launch of eProtein Discovery platform
Nuclera raises $42.5M in first close of Series B for desktop protein printer
Nuclera, a biotech company developing cutting-edge benchtop protein printing technologies, announces that the first close of its Series B financing has raised $42.5 million. The funds raised will be used to accelerate the development and commercialization of its eProtein™ desktop bioprinter.